2023美国风湿病学会与美国髋膝关节外科医师协会临床实践指南:对有症状的中重度骨关节炎或晚期有症状的骨坏死继发关节炎且非手术治疗无效的患者,择期髋或膝关节置换术最佳时机的推荐
该指南由美国风湿病学会与美国髋膝关节外科医师协会制定,针对有症状且影像学证实的中重度骨关节炎或晚期有症状的骨坏死继发关节炎、非手术治疗无效并选择择期全髋或全膝关节置换术的患者,提出关于手术最佳时机的循证推荐。指南基于13个PICO问题系统检索文献,采用GRADE方法评级证据质量,由包括13名医师和患者在内的投票专家组达成共识。推荐涉及延迟手术以进行额外非手术治疗、尼古丁减量或戒除、血糖控制、肥胖、严重畸形或骨丢失及神经性关节等情形,所有推荐证据质量均为低或极低。
要点
- 有条件推荐不延迟全髋或全膝关节置换术以进行额外非手术治疗,包括物理治疗、非甾体抗炎药、助行器和关节腔内注射。
- 有条件推荐延迟全髋或全膝关节置换术以进行尼古丁减量或戒除。
- 有条件推荐糖尿病患者延迟手术以改善血糖控制,但未确定具体指标或水平。
核心结论
- 该指南针对有症状且影像学证实的中重度骨关节炎或晚期有症状的骨坏死继发关节炎、非手术治疗无效并选择择期全髋或全膝关节置换术的患者,提供关于手术最佳时机的循证推荐,以改善疼痛、功能、感染、住院和1年死亡等患者重要结局。
- 作者承认证据质量低,主要由于间接性,并希望未来研究能进一步细化推荐。
研究设计与样本
- 该指南由美国风湿病学会与美国髋膝关节外科医师协会制定,基于13个临床相关的PICO问题,经系统文献综述后采用GRADE方法评级证据质量并制作证据表。
- 投票专家组包括13名医师和患者,讨论PICO问题直至就推荐的方向(支持/反对)和强度(强/有条件)达成共识。
主要发现
- 专家组有条件推荐不延迟全髋或全膝关节置换术以进行额外非手术治疗,包括物理治疗、非甾体抗炎药、助行器和关节腔内注射。
- 专家组有条件推荐延迟全髋或全膝关节置换术以进行尼古丁减量或戒除。
- 专家组有条件推荐糖尿病患者延迟手术以改善血糖控制,但未确定具体指标或水平。
- 专家组共识认为肥胖本身不是延迟手术的理由,但应强烈鼓励减重,并讨论手术风险增加。
- 专家组有条件推荐不延迟严重畸形或骨丢失患者以及神经性关节患者的手术。
关键数值与推荐
- 所有推荐的证据质量均评级为低或极低。
- 有条件推荐不延迟全髋或全膝关节置换术以进行额外非手术治疗(物理治疗、非甾体抗炎药、助行器、关节腔内注射)。
- 有条件推荐延迟全髋或全膝关节置换术以进行尼古丁减量或戒除。
- 有条件推荐糖尿病患者延迟手术以改善血糖控制,但未确定具体指标或水平。
- 有条件推荐不延迟严重畸形或骨丢失患者以及神经性关节患者的手术。
临床怎么用
- 对于有症状且影像学证实的中重度骨关节炎或晚期有症状的骨坏死继发关节炎、非手术治疗无效并选择择期全髋或全膝关节置换术的患者,专家组有条件推荐不延迟手术以进行额外非手术治疗。
- 专家组有条件推荐延迟全髋或全膝关节置换术以进行尼古丁减量或戒除。
- 对于糖尿病患者,专家组有条件推荐延迟手术以改善血糖控制,但未确定具体指标或水平。
- 专家组共识认为肥胖本身不是延迟手术的理由,但应强烈鼓励减重,并讨论手术风险增加。
- 对于严重畸形或骨丢失患者以及神经性关节患者,专家组有条件推荐不延迟手术。
局限性
- 所有推荐的证据质量均评级为低或极低。
- 作者承认证据质量低主要由于间接性,并希望未来研究能进一步细化推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty to improve patient-important outcomes including, but not limited to, pain, function, infection, hospitalization, and death at 1 year for patients with symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis of the hip or knee who have previously attempted nonoperative therapy, and for whom nonoperative therapy was ineffective, and who have chosen to undergo elective hip or knee arthroplasty (collectively referred to as TJA). METHODS: We developed 13 clinically relevant population, intervention, comparator, outcomes (PICO) questions. After a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the quality of evidence (high, moderate, low, or very low), and evidence tables were created. A Voting Panel, including 13 physicians and patients, discussed the PICO questions until consensus was achieved on the direction (for/against) and strength (strong/conditional) of the recommendations. RESULTS: The panel conditionally recommended against delaying TJA to pursue additional nonoperative treatment including physical therapy, nonsteroidal antiinflammatory drugs, ambulatory aids, and intraarticular injections. It conditionally recommended delaying TJA for nicotine reduction or cessation. The panel conditionally recommended delay for better glycemic control for patients who have diabetes mellitus, although no specific measure or level was identified. There was consensus that obesity by itself was not a reason for delay, but that weight loss should be strongly encouraged, and the increase in operative risk should be discussed. The panel conditionally recommended against delay in patients who have severe deformity or bone loss, or in patients who have a neuropathic joint. Evidence for all recommendations was graded as low or very low quality. CONCLUSION: This guideline provides evidence-based recommendations regarding the optimal timing of TJA in patients who have symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy was ineffective to improve patient-important outcomes, including pain, function, infection, hospitalization, and death at 1 year. We acknowledge that the evidence is of low quality primarily due to indirectness and hope future research will allow for further refinement of the recommendations.
引用
- Hannon CP, Goodman SM, Austin MS, et al. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Rheumatol. 2023. PMID: 37746897. doi:10.1002/art.42630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。